Blog Archives

Effect of unilateral and bilateral STN stimulation and levodopa on distal and proximal alternating movement of the upper limb in Parkinson’s disease

Radics P, Erőss L, Takáts A, Heldman D, Giuffrida J, Entz L, Fabó D, Tamás G International Conference on Deep Brain Stimulation. Dusseldorf, Germany, 2013

Tagged with: , , , , ,

Deep brain stimulation programming in PD using functional motor symptom response tuning maps

T. Mera, Vitek J, J. Giuffrida International Conference on Deep Brain Stimulation. Dusseldorf, Germany, 2013

Tagged with: , , , , ,

Test-Retest Reliability of a Parkinson’s Disease Monitoring System

Dustin Heldman, Alberto Espay, Peter LeWitt, and J. Giuffrida 65th Annual Meeting of the American Academy of Neurology, San Diego, CA, 2013

Tagged with: , , , , ,

Deep brain stimulation programming in Parkinson’s disease using functional motor symptom response tuning maps

T. Mera, J. Vitek, J. Giuffrida 65th Annual Meeting of the American Academy of Neurology, San Diego, CA, 2013

Tagged with: , , , , , , ,

Home-based Motion Sensor Monitoring for Parkinson’s Disease Clinical Trials

View Poster D. Heldman, A. Espay, P. LeWitt, J. Giuffrida 3rd World Parkinson Congress. Montreal, Canada, 2013

Tagged with: , , , ,

Quantitative Analysis Of Gait And Balance Response To Deep Brain Stimulation In Parkinson’s Disease

T. Mera, D. Filipkowski, D. Riley, C. Whitney, B. Walter, S. Gunzler, J. Giuffrida Gait & Posture. 2013 May;38(1):109-14

Tagged with: , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The

Tagged with: , , , , , , , , , , , , , , ,

Active-Assisted Cycling Improves Tremor and Bradykinesia in Parkinson’s Disease

A. Ridgel, C. Peacock, E. Fickes, C. Kim Arch Phys Med Rehabil. 2012 Nov;93(11):2049-54

Tagged with: , , , , ,

PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess

Tagged with: , , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress

Tagged with: , , , , , , , , , , , , , , , ,